« NIH's Collins Clamors for Public War Chest to Fund Rare Disease Trials | Main | Adimab Scores 4th Big Pharma Deal »
Fierce Biotech reports that Japan's Takeda will set aside 50 billion Yen per year for the next 3 years to fund the acquisition of new products for its portfolio. That's 50 billion incremental Yen to what it normally sets aside for this purpose.
Got a new drug to sell? You now have another company to call!
Posted by Bruce Lehr July 9th 2010.
| | |
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b013485530abb970c
Listed below are links to weblogs that reference Takeda - What Will 50 billion Yen Get Me per Year? Let's See!:
The comments to this entry are closed.
Comments